M&A Deal Summary

EVIO Labs Acquires Leading Edge Pharms

On July 12, 2021, EVIO Labs acquired consumer products company Leading Edge Pharms

Acquisition Highlights
  • This is EVIO Labs’ 1st transaction in the Consumer Products sector.
  • This is EVIO Labs’ 1st transaction in the United States.
  • This is EVIO Labs’ 1st transaction in Nevada.

M&A Deal Summary
Date 2021-07-12
Target Leading Edge Pharms
Sector Consumer Products
Buyer(s) EVIO Labs
Deal Type Add-on Acquisition

Target

Leading Edge Pharms

Henderson, Nevada, United States
Leading Edge Pharms, is a biotechnology company focused on the research, development, and commercialization of novel cannabinoid therapies and innovative drug delivery systems. LEP is the developer of CANNAVERA, a line of topical pain relief products available online with independent pharmacies and drug stores across the Mid-South and the North-East United States. All LEP products are manufactured in FDA-registered facilities adhering to Current Good Manufacturing Practices. Leading Edge Pharms was formed in 2016 and is based in Henderson, Nevada.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

EVIO Labs

Henderson, Nevada, United States
Category Company
Sector Life Science
Employees18
Revenue 4M USD (2019)
DESCRIPTION

EVIO Labs is a provider of analytical testing services for cannabis, hemp, and CBD products. The company maintains full-service, licensed, and accredited laboratory operations in California, Oregon, and Canada. It also provides clients with quality analytical R&D and consulting services to help them produce the best, compliant products.

DEAL STATS #
Overall 1 of 1
Sector (Consumer Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Nevada) 1 of 1
Country (United States) 1 of 1
Year (2021) 1 of 1
Mergr

Product

Company

Legal